Burton pharma firm in £120m double swoop
Clinigen, the Burton-based pharma firm, has announced a double acquisition.
The company has swooped for CSM Parent, a specialist provider of packaging, labelling, warehousing and distribution services based in Europe and the US, for £114.2m
Meanwhile, Clinigen has bought Swiss-based iQone Healthcare Holding for £6.7m.
iQone is based near Geneva with operations across Europe in France, Germany, Italy, Spain and Switzerland. Its team sets up and delivers Managed Access Programs and commercial solutions across Europe.
The Group has also today published results for the year to 30 June 2018 which showed adjusted gross profit up 14% to £140.1m. It is looking at raising £80m through a share placement.
Shaun Chilton, group chief executive officer, said: “We are now established as a leading international expert and partner in the increasingly complex global supply and distribution of both unlicensed and licensed medicines.
“Our continued ambition is to be the global trusted leader in access to medicines. With that in mind, we continue to execute our buy and build strategy with the purchase of two niche, hospital medicines, as well as today’s announcements on the acquisitions of CSM and iQone, which create a specialist European infrastructure to benefit all of Clinigen’s businesses.”